-
Electronic (PDF)
-
Electronic (Online Access)
-
Enterprisewide
-
Enterprisewide
The Medical Device Market: Germany
Espicom Business Intelligence Ltd, April 2013, Pages: 110
Espicom’s in-depth medical device market reports are ideal for executives wanting to understand the key drivers in medical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
Germany is the third largest medical device market in the world, ranking behind the USA and Japan. In 2011, the German medical device market is estimated at US$19.5 billion, equal to US$240 per capita.
Although in decline, the population of Germany still accounts for around 20% of the total population of western Europe with an estimated 81.6 million inhabitants in 2011.
At over 11% of GDP, healthcare expenditure is at a high level but is increasingly constrained. The domestic market remains tight, with continued downward pressure on prices. Government funding of hospitals in recent years has remained static, therefore hospitals in the public sector are maintaining existing equipment rather than investing in new appliances. This has led to domestic producers becoming increasingly reliant on the export market.
Germany has a history of producing high quality medical equipment, with particular emphasis on diagnostic imaging, dental products and optical technologies. The country has a handful of large producers, headed by Siemens, B. Braun and Fresenius. Total production is estimated to be in the region of 20 billion euros.
Despite a strong domestic manufacturing industry, imports, which totalled US$13.8 billion in 2009, supply around three-quarters of the medical market.
Following the re-election of Angela Merkel as Chancellor, Germany now has its first centre-right government in more than a decade. The coalition government comprising the centre-right Christian Democratic Union and the liberal Free Democratic Party has committed itself to a healthcare reform programme that aims to rein in expenditure growth, whilst increasing financial resources through higher health insurance contributions.
Major healthcare reforms were introduced in January 2004 and in July 2007. One of the aims has been to increase competition between health insurers, which in turn is giving rise to a more competitive operating environment for suppliers of healthcare goods and services.
Includes 3 quarterly updated outlook reports!
Please note: Report sections are periodically updated and some sections may have been updated more recently than the publication date given for the full report.
EXECUTIVE SUMMARY
Introduction
Pharmaceutical Market Analysis
Size
Market Structure
Retail Pharmaceutical Expenditure
GKV Drug Expenditure
Hospital-only Drugs Market
Generics Sector
OTC Sector
Projections & Outlook
Imports
Domestic Manufacturing
Domestic Production
Trade Association(s)
Bundesverband der Pharmazeutischen Industrie (BPI)
Bundesfachverband der Arnzeimittelsteller (BAH)
Verband Forschender Arnzeimittelhersteller (VFA)
Deutscher Generika Verband (formerly VAP)
Research-based Manufacturers
Bayer
Berlin-Chemie AG
Boehringer Ingelheim
Fresenius Kabi AG
Merck KGaA
Nycomed (Altana Pharma)
Generic Manufacturers
Accedo Arzneimittel GmbH
Actavis Deutschland
betapharm
CT-Arzneimittel
Heumann Pharma Generics/Torrent Pharmaceuticals
Hexal
Hospira Deutschland GmbH
Mylan Dura (formerly Merck Dura)
Neuraxpharm
ratiopharm
Ribosepharm
Sandoz
Stada Arzneimittel
Winthrop Arzneimittel
Exports
Research & Development
Pharmaceutical Regulatory Analysis
Pharmaceutical Regulation
EU Drug Regulation
Centralised Procedure
EMEA
Generic Drugs
Pricing & Reimbursement
Pricing
Reimbursement
GKV Negotiates Pharmaceutical Discount Contracts
Generic Substitution Policies
Compulsory Manufacturer Rebates
AVWG, 2006
Intellectual Property
Supplementary Protection Certificates
Data Exclusivity
Pharmaceutical Distribution
Wholesaling
Anzag
Celesio
Noweda eG
Phoenix AG
Sanacorp Pharmahandel AG
Retailing
Healthcare Analysis
Demographics
Population
Birth Rate
Death Rate
Infant Mortality
Life Expectancy at Birth
Public Health
Causes of Death
Incidence of Communicable Diseases
HIV/AIDS
Healthcare System
Federal Ministries
Länder Institutions
Healthcare System Reform 2007
Health Expenditure
Healthcare Infrastructure
Inpatient Analysis
Ambulatory Care
Healthcare Personnel
DIRECTORY
Methodology & Sources
List of Tables
Summary of Key Data Projections, 2008-2013
Summary of the German Pharmaceutical Market, 2008
Total Retail Pharmaceutical Expenditure, 2001-07 (Euro billions)
GKV Prescription Drug Expenditure, 1996-2007
GKV Drug Spending by Therapeutic Category, 2005-07 (Euro millions)
GKV Drug Spending by Therapeutic Category, 2005-07 (Packages prescribed, millions)
Top 30 selling Drug Brands, 2007
GKV Pharmaceutical Expenditure by Land, 2006-07 (million euros)
Sales of Hospital-only Pharmaceuticals, 2002-06 (Million Euros)
Prescriptions of Hospital-only Pharmaceuticals, 2002-06 (000s)
Average Price of Hospital-only Pharmaceuticals, 2002-06 (Euros)
Generic market share by volume and value, 2001-07 (%)
Generic Spending, 2001-2006 (million euros)
Generics in the ‘Generic Capable’ Market, 2001-2007 (%)
Potential Generic Savings for 20 Leading Products, 2007
OTC Market by Category, 2001-07 (million euros)
Market Projections, 2008-2013
Market Projections By Category, 2008-2013 (million euros)
Market Projections By Category, 2008-2013 (US$ millions)
Per Capita Market Projections By Category, 2008-2013 (US$)
SWOT Analysis of the German Pharmaceutical Market, 2008
Espicom Analysis of Germany’s Health Sector
Imports of Pharmaceuticals by Category, 2003-2007 (US$000s)
Import Trends
Leading Suppliers of Raw Materials, 2007 (US$000s)
Leading Suppliers of Medicaments, 2007 (US$000s)
Total Pharma Production, 1992-2007 (Euro billions)
Eurostat Production Data, 2003-07 (Euro millions)
Exports of Pharmaceuticals, 2003-07 (US$000s)
Export Trends
Leading Destinations, 2007 (US$000s)
Public and Hospital Pharmacies, 2002-06
Pharmacies by Land, 2006
Pharmacists by Land, 2002-06 (Rate per 100,000 population)
Summary of Demographic Data
Projected Population, 2008-2013
Causes of Death, 2006-07
Healthcare Expenditure, 2008
Health Expenditure by Source, 2002-06 (million euros)
Projected Health Expenditure, 2008-2013
Hospitals & Beds
Hospital Bed Projections, 2008-2013
Total Doctors & Dentists, 2002-06
Projected Total Number of Physicians, 2008-2013
Physicans by Specialty, 2005-07
- Bundesverband Medizintechnologie e.V. (formerly Bundesfachverband Medizinprodukteindustrie e.V.)
- Zentral Verband der Elektrotechnischen Industrie e.V. (ZVEI)
- Spectaris
- B. Braun
- Carl Zeiss AG
- Dräger Medical
- Fresenius
- Heraeus
- Maquet
- Siemens
- Länder Institutions
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW5
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
